Td/IPV (2025)
Who
| Buyer | UK Health Security Agency — not a council we hold |
| Supplier | Aventis Pharma ltd t/a Sanofi |
What
The provision of low dose diphtheria tetanus and inactivated polio vaccine to be used as part of the national immunisation programme. Deliveries will be required over a period of 3 years, with an option to extend for up to an additional 24 months. Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier. The opportunity is not split into lots as the requirement is for a specific vaccine.
Dates and source
| Runs | 1 Oct 2025 to 30 Sep 2030 |
| OCID | ocds-b5fd17-e7565dd3-8f2e-442d-a552-89b10586eec5 |
| Notice | Read it on Contracts Finder |
Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.